RAMASUBBU, S. K.; DAKSHINAMURTHY, S.; PALEPU, S.; BANDYOPADHYAY, A.; RAJENDRAN, S. K. Rimegepant: first novel oral calcitonin gene-related peptide inhibitor for migraine. International Journal of Basic & Clinical Pharmacology, [S. l.], v. 9, n. 5, p. 829–832, 2020. DOI: 10.18203/2319-2003.ijbcp20201768. Disponível em: https://www.ijbcp.com/index.php/ijbcp/article/view/4120. Acesso em: 16 jul. 2024.